U.S. Navy Awards Sev1Tech $45 Million Contract for Logistics IT Support
Sev1Tech to provide services for the Program Executive Office for Manpower, Logistics, and Business Solutions’…
News
Epic Bio to Present at the Upcoming BMO Life Sciences Private Company Showcase
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
Epic Bio to Present at the Upcoming BMO Life Sciences Private Company Showcase
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th
Tel Aviv, Israel / Vancouver, Canada, Oct. 05, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th
Tel Aviv, Israel / Vancouver, Canada, Oct. 05, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
Study Published in Science Translational Medicine Shows Exbaq’s Experimental Vaccine Protects Against Many of the Most Dangerous Antibiotic Resistant Superbugs Causing Hospital Acquired Infections
Vaccine Stimulates the Body’s Macrophages, Engulfing and Killing Gram Positive/Negative Bacteria, and Fungi Vaccine provides…
Study Published in Science Translational Medicine Shows Exbaq’s Experimental Vaccine Protects Against Many of the Most Dangerous Antibiotic Resistant Superbugs Causing Hospital Acquired Infections
Vaccine Stimulates the Body’s Macrophages, Engulfing and Killing Gram Positive/Negative Bacteria, and Fungi Vaccine provides…
Precision Neuroscience Acquires U.S. Manufacturing Facility and Receives FDA Breakthrough Device Designation
The purchase allows the brain–computer interface company to oversee the end-to-end fabrication of its microelectrode…
Precision Neuroscience Acquires U.S. Manufacturing Facility and Receives FDA Breakthrough Device Designation
The purchase allows the brain–computer interface company to oversee the end-to-end fabrication of its microelectrode…
GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immunology Demonstrating a Key Role of Type 1 iNKT Cells in Modulating Various Fibrotic Conditions
In several murine models of chronic inflammation and fibrosis, as well as in humans, it…
GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immunology Demonstrating a Key Role of Type 1 iNKT Cells in Modulating Various Fibrotic Conditions
In several murine models of chronic inflammation and fibrosis, as well as in humans, it…
Fortress Biotech to Present at ROTH MKM 2023 Healthcare Opportunities Conference
MIAMI, Oct. 05, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative…
Fortress Biotech to Present at ROTH MKM 2023 Healthcare Opportunities Conference
MIAMI, Oct. 05, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative…
Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client
VKVP Haulage adopts Fingerprint Drug Screening System to help drive proactive drug testing policy Auctus…
Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client
VKVP Haulage adopts Fingerprint Drug Screening System to help drive proactive drug testing policy Auctus…
NurExone Biologic to Present Exosome-Based Therapy for Spinal Cord Injury in Regenerative Medicine Session at Upcoming Extracellular Vesicles Forum
TORONTO and HAIFA, Israel, Oct. 05, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX)…
NurExone Biologic to Present Exosome-Based Therapy for Spinal Cord Injury in Regenerative Medicine Session at Upcoming Extracellular Vesicles Forum
TORONTO and HAIFA, Israel, Oct. 05, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX)…
Evaxion Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
COPENHAGEN, Denmark, Oct. 05, 2023 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or…
Evaxion Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
COPENHAGEN, Denmark, Oct. 05, 2023 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or…
Dyadic’s C1 Platform Selected by the Vaccine and Immunotherapy Center (“VIC”) at Massachusetts General Hospital as Part of VIC’s $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic Vaccines for Infectious Diseases
JUPITER, Fla., Oct. 05, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”,…